These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25065779)

  • 1. Relative receptor tyrosine kinases and anti-apoptotic transcripts hold potential for predicting inferior outcome in adult acute myeloid leukemia: a prospective pilot study.
    Sharawat SK; Vishnubhatla S; Bakhshi R; Raina V; Kumar L; Sharma A; Bakhshi S
    Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):501-508.e2. PubMed ID: 25065779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High receptor tyrosine kinase (FLT3, KIT) transcript versus anti-apoptotic (BCL2) transcript ratio independently predicts inferior outcome in pediatric acute myeloid leukemia.
    Sharawat SK; Bakhshi R; Vishnubhatla S; Bakhshi S
    Blood Cells Mol Dis; 2015 Jan; 54(1):56-64. PubMed ID: 25216797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased coexpression of c-KIT and FLT3 receptors on myeloblasts: independent predictor of poor outcome in pediatric acute myeloid leukemia.
    Sharawat SK; Gupta R; Raina V; Kumar L; Sharma A; Iqbal S; Bakhshi R; Vishnubhatla S; Bakhshi S
    Cytometry B Clin Cytom; 2013; 84(6):390-7. PubMed ID: 23740774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Bcl2 protein predicts chemoresistance in acute myeloid leukemia: its correlation with FLT3.
    Mehta SV; Shukla SN; Vora HH
    Neoplasma; 2013; 60(6):666-75. PubMed ID: 23906301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of tyrosine kinases gene mutations in core binding factor related acute myeloid leukemia and its clinical significance].
    Qiao M; Li WY; Sun AN; Chen SN; Liang JY; Ding ZX; Feng YF; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):679-83. PubMed ID: 22339826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
    Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H
    Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Core binding factor acute myeloid leukaemia and c-KIT mutations.
    Riera L; Marmont F; Toppino D; Frairia C; Sismondi F; Audisio E; Di Bello C; D'Ardia S; Di Celle PF; Messa E; Inghirami G; Vitolo U; Pich A
    Oncol Rep; 2013 May; 29(5):1867-72. PubMed ID: 23467883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of FLT3-internal tandem duplication allele burden and white blood cell count on the outcome in patients with intermediate-risk karyotype acute myeloid leukemia.
    How J; Sykes J; Gupta V; Yee KW; Schimmer AD; Schuh AC; Minden MD; Kamel-Reid S; Brandwein JM
    Cancer; 2012 Dec; 118(24):6110-7. PubMed ID: 22736495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study.
    Whitman SP; Archer KJ; Feng L; Baldus C; Becknell B; Carlson BD; Carroll AJ; Mrózek K; Vardiman JW; George SL; Kolitz JE; Larson RA; Bloomfield CD; Caligiuri MA
    Cancer Res; 2001 Oct; 61(19):7233-9. PubMed ID: 11585760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of KIT and FLT3 mutations in acute myeloid leukemia with different subtypes.
    Zaker F; Mohammadzadeh M; Mohammadi M
    Arch Iran Med; 2010 Jan; 13(1):21-5. PubMed ID: 20039765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and prognostic significance of c-KIT mutations in core binding factor acute myeloid leukemia: a comprehensive large-scale study from a single Chinese center.
    Qin YZ; Zhu HH; Jiang Q; Jiang H; Zhang LP; Xu LP; Wang Y; Liu YR; Lai YY; Shi HX; Jiang B; Huang XJ
    Leuk Res; 2014 Dec; 38(12):1435-40. PubMed ID: 25449688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML).
    Del Poeta G; Venditti A; Del Principe MI; Maurillo L; Buccisano F; Tamburini A; Cox MC; Franchi A; Bruno A; Mazzone C; Panetta P; Suppo G; Masi M; Amadori S
    Blood; 2003 Mar; 101(6):2125-31. PubMed ID: 12424199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CD135/CD117 on Prognosis and Overall Survival of Acute Myeloid Leukemia.
    Raeisi M; Nikhanfar AR; Nejate B; Movassaghpour Akbari AA; Dolatkhah R; Roosta Y; Sanaat Z
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2625-2631. PubMed ID: 31554356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of c-kit mutation detection method sensitivity in prognostic analyses of t(8;21)(q22;q22) acute myeloid leukemia.
    Wakita S; Yamaguchi H; Miyake K; Mitamura Y; Kosaka F; Dan K; Inokuchi K
    Leukemia; 2011 Sep; 25(9):1423-32. PubMed ID: 21606963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of BCL2L12 gene in de novo acute myeloid leukemia and its clinical implications].
    Yu MX; Lu Y; Mu QT; Wang Q; Chen ZM; Lou JY; Jin J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Oct; 30(5):544-8. PubMed ID: 24078567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of bcl-2 expression as modulator of fas mediated apoptosis in acute leukemia.
    Aref S; Salama O; Al-Tonbary Y; Mansour A
    Hematology; 2004 Apr; 9(2):113-21. PubMed ID: 15203866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of Bcl-XL gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia.
    Schaich M; Illmer T; Seitz G; Mohr B; Schäkel U; Beck JF; Ehninger G
    Haematologica; 2001 May; 86(5):470-7. PubMed ID: 11410409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association.
    Renneville A; Boissel N; Nibourel O; Berthon C; Helevaut N; Gardin C; Cayuela JM; Hayette S; Reman O; Contentin N; Bordessoule D; Pautas C; Botton Sd; Revel Td; Terre C; Fenaux P; Thomas X; Castaigne S; Dombret H; Preudhomme C
    Leukemia; 2012 Jun; 26(6):1247-54. PubMed ID: 22289988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of c-kit and JAK2 gene mutations in t(8;21) acute myeloid leukemia].
    Li WY; Sun AN; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):797-801. PubMed ID: 19176031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.